↓ Skip to main content

Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, September 2011
Altmetric Badge

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
22 Mendeley
Title
Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials
Published in
Journal of Cancer Research and Clinical Oncology, September 2011
DOI 10.1007/s00432-011-1052-7
Pubmed ID
Authors

Wei-Xiang Qi, Zan Shen, Yang Yao

Abstract

To assess the efficacy and toxicity of the addition of estramustine to docetaxel-based chemotherapy for the treatment of castration-resistant prostate cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 18%
Researcher 3 14%
Student > Master 3 14%
Other 2 9%
Student > Postgraduate 2 9%
Other 4 18%
Unknown 4 18%
Readers by discipline Count As %
Medicine and Dentistry 8 36%
Computer Science 2 9%
Social Sciences 2 9%
Biochemistry, Genetics and Molecular Biology 1 5%
Immunology and Microbiology 1 5%
Other 3 14%
Unknown 5 23%